from syringes to insulin pens, to an insulin pump, or even with an inhaler. Maintaining blood glucose levels helps reduce the risk of diabetes complications, such as blindness and the loss of limbs.

Building upon its existing work with IBM Watson Health and Glooko, Novo Nordisk aims to integrate insulin dosing data from connected pen devices with its partners' open ecosystems and diabetes ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global insulin delivery pens market size was exhibited at USD 26,412 million in 2024 and is projected to grow USD 58,086 ...

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management ... brings together a pre-filled insulin pen, the TempoSmart app and ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker ...

In healthy individuals, the body produces all the insulin that it needs. However, people with diabetes either don't ... Once you open a vial of insulin or pen, another expiration date starts.

parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized patients with diabetes mellitus requiring subcutaneous ...